The CBI has registered a case against two Mumbai-based firms, including multinational Johnson and Johnson Ltd, for allegedly causing Rs 50 crore losses to the government besides cheating consumers by overpricing drugs.

Johnson and Johnson was found to be allegedly availing of exemption from price approval provided to small scale drug units by fraudulently floating a small scale unit N R Jet Enterprises. It was also showing that such drugs and medicines were not manufactured by it, said a CBI release. During investigations, the agency found that Jet Enterprises was controlled by employees of Johnson and Johnson and some of the products being manufactured by it were earlier being produced by the multinational, the release said.

PTI